Abstract
Antiviral drugs were rapidly implemented into clinical practice for the treatment of high-risk patients with COVID-19, prompting the development of statewide guidelines. This South-Australian study reviewed guideline adherence, assessed prescribing patterns and highlighted the inappropriate management of relative drug–drug interactions and dosing for renal function. Additionally, it evaluated the impact of inappropriate antiviral drug use and suggested methods to improve quality use of medicines.
Original language | English |
---|---|
Pages (from-to) | 183-186 |
Number of pages | 4 |
Journal | Internal Medicine Journal |
Volume | 54 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2024 |
Keywords
- COVID-19
- living guidelines
- molnupiravir
- nirmatrelvir/ritonavir
- prescribing
- remdesivir